Your browser doesn't support javascript.
loading
Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients.
Célestin Schartz, Noël Emile; Chevret, Sylvie; Paz, Carolina; Kerob, Delphine; Verola, Olivier; Morel, Patrice; Lebbé, Céleste.
Affiliation
  • Célestin Schartz NE; Department of Dermatology 2, Hôpital Saint Louis AP-HP, Paris, France. noel.schartz@noos.fr
J Am Acad Dermatol ; 58(4): 585-91, 2008 Apr.
Article in En | MEDLINE | ID: mdl-18068265
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma, Kaposi / Skin Neoplasms / Adjuvants, Immunologic / HIV Seronegativity / Aminoquinolines Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Am Acad Dermatol Year: 2008 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma, Kaposi / Skin Neoplasms / Adjuvants, Immunologic / HIV Seronegativity / Aminoquinolines Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Am Acad Dermatol Year: 2008 Document type: Article Affiliation country: Country of publication: